| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |